-
1
-
-
48349096183
-
Attention should be given to multiplicity issues in systematic reviews
-
Bender R, Bunce C, Clarke M, Gates S, Lange S, Pace NL, et al. Attention should be given to multiplicity issues in systematic reviews. J Clin Epidemiol 2008;61:857-65.
-
(2008)
J Clin Epidemiol
, vol.61
, pp. 857-865
-
-
Bender, R.1
Bunce, C.2
Clarke, M.3
Gates, S.4
Lange, S.5
Pace, N.L.6
-
2
-
-
69949100651
-
Disagreements in meta-analyses using outcomes measured on continuous or rating scales: Observer agreement study
-
Tendal B, Higgins JP, Juni P, Hrobjartsson A, Trelle S, Nuesch E, et al. Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study. BMJ 2009;339:b3128.
-
(2009)
BMJ
, vol.339
-
-
Tendal, B.1
Higgins, J.P.2
Juni, P.3
Hrobjartsson, A.4
Trelle, S.5
Nuesch, E.6
-
3
-
-
34247624271
-
Meta-analysis: Chondroitin for osteoarthritis of the knee or hip
-
Reichenbach S, Sterchi R, Scherer M, Trelle S, Burgi E, Burgi U, et al. Meta-analysis: chondroitin for osteoarthritis of the knee or hip. Ann Intern Med 2007;146:580-90. (Pubitemid 351650539)
-
(2007)
Annals of Internal Medicine
, vol.146
, Issue.8
, pp. 580-590
-
-
Reichenbach, S.1
Sterchi, R.2
Scherer, M.3
Trelle, S.4
Burgi, E.5
Burgi, U.6
Dieppe, P.A.7
Juni, P.8
-
8
-
-
34547491316
-
Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia
-
CD004364
-
Furukawa TA, Watanabe N, Churchill R. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev 2007;1:CD004364.
-
(2007)
Cochrane Database Syst Rev
, vol.1
-
-
Furukawa, T.A.1
Watanabe, N.2
Churchill, R.3
-
9
-
-
35648997712
-
Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD)
-
CD005333
-
Gava I, Barbui C, Aguglia E, Carlino D, Churchill R, De Vanna M, et al. Psychological treatments versus treatment as usual for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev 2007;2:CD005333.
-
(2007)
Cochrane Database Syst Rev
, vol.2
-
-
Gava, I.1
Barbui, C.2
Aguglia, E.3
Carlino, D.4
Churchill, R.5
De Vanna, M.6
-
11
-
-
42749098607
-
Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders
-
CD005473
-
Ipser JC, Carey P, Dhansay Y, Fakier N, Seedat S, Stein DJ. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. Cochrane Database Syst Rev 2006;4:CD005473.
-
(2006)
Cochrane Database Syst Rev
, vol.4
-
-
Ipser, J.C.1
Carey, P.2
Dhansay, Y.3
Fakier, N.4
Seedat, S.5
Stein, D.J.6
-
12
-
-
33750093798
-
Exercise in prevention and treatment of anxiety and depression among children and young people
-
CD004691
-
Larun L, Nordheim LV, Ekeland E, Hagen KB, Heian F. Exercise in prevention and treatment of anxiety and depression among children and young people. Cochrane Database Syst Rev 2006;3:CD004691.
-
(2006)
Cochrane Database Syst Rev
, vol.3
-
-
Larun, L.1
Nordheim, L.V.2
Ekeland, E.3
Hagen, K.B.4
Heian, F.5
-
14
-
-
42749105095
-
Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home
-
CD004510
-
Mistiaen P, Poot E. Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home. Cochrane Database Syst Rev 2006;4:CD004510.
-
(2006)
Cochrane Database Syst Rev
, vol.4
-
-
Mistiaen, P.1
Poot, E.2
-
15
-
-
33750130602
-
Humidified air inhalation for treating croup
-
CD002870
-
Moore M, Little P. Humidified air inhalation for treating croup. Cochrane Database Syst Rev 2006;3:CD002870.
-
(2006)
Cochrane Database Syst Rev
, vol.3
-
-
Moore, M.1
Little, P.2
-
16
-
-
77950153525
-
School-based secondary prevention programmes for preventing violence
-
CD004606
-
Mytton J, DiGuiseppi C, Gough D, Taylor R, Logan S. School-based secondary prevention programmes for preventing violence. Cochrane Database Syst Rev 2006;3:CD004606.
-
(2006)
Cochrane Database Syst Rev
, vol.3
-
-
Mytton, J.1
DiGuiseppi, C.2
Gough, D.3
Taylor, R.4
Logan, S.5
-
17
-
-
37649028824
-
Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents
-
CD004856
-
O'Kearney RT, Anstey KJ, Von Sanden C. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents. Cochrane Database Syst Rev 2006;4:CD004856.
-
(2006)
Cochrane Database Syst Rev
, vol.4
-
-
O'Kearney, R.T.1
Anstey, K.J.2
Von Sanden, C.3
-
19
-
-
33750114364
-
Acupuncture for neck disorders
-
CD004870
-
Trinh KV, Graham N, Gross AR, Goldsmith CH, Wang E, Cameron ID, et al. Acupuncture for neck disorders. Cochrane Database Syst Rev 2006;3:CD004870.
-
(2006)
Cochrane Database Syst Rev
, vol.3
-
-
Trinh, K.V.1
Graham, N.2
Gross, A.R.3
Goldsmith, C.H.4
Wang, E.5
Cameron, I.D.6
-
20
-
-
42749104501
-
Psychological interventions for needle-related procedural pain and distress in children and adolescents
-
CD005179
-
Uman LS, Chambers CT, McGrath PJ, Kisely S. Psychological interventions for needle-related procedural pain and distress in children and adolescents. Cochrane Database Syst Rev 2006;4:CD005179.
-
(2006)
Cochrane Database Syst Rev
, vol.4
-
-
Uman, L.S.1
Chambers, C.T.2
McGrath, P.J.3
Kisely, S.4
-
21
-
-
36148977765
-
EMG biofeedback for the recovery of motor function after stroke
-
CD004585
-
Woodford H, Price C. EMG biofeedback for the recovery of motor function after stroke. Cochrane Database Syst Rev 2007;2:CD004585.
-
(2007)
Cochrane Database Syst Rev
, vol.2
-
-
Woodford, H.1
Price, C.2
-
22
-
-
44949121809
-
Low level laser therapy for nonspecific low-back pain
-
CD005107
-
Yousefi-Nooraie R, Schonstein E, Heidari K, Rashidian A, Akbari-Kamrani M, Irani S, et al. Low level laser therapy for nonspecific low-back pain. Cochrane Database Syst Rev 2007;2:CD005107.
-
(2007)
Cochrane Database Syst Rev
, vol.2
-
-
Yousefi-Nooraie, R.1
Schonstein, E.2
Heidari, K.3
Rashidian, A.4
Akbari-Kamrani, M.5
Irani, S.6
-
23
-
-
0026692671
-
The Galway study of panic disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: A placebo controlled trial
-
Fahy TJ, O'Rourke D, Brophy J, Schazmann W, Sciascia S. The Galway study of panic disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial. J Affect Disord 1992;25:63-75.
-
(1992)
J Affect Disord
, vol.25
, pp. 63-75
-
-
Fahy, T.J.1
O'Rourke, D.2
Brophy, J.3
Schazmann, W.4
Sciascia, S.5
-
24
-
-
0022458899
-
Two-year follow-up of exposure and imipramine treatment of agoraphobia
-
Mavissakalian M, Michelson L. Two-year follow-up of exposure and imipramine treatment of agoraphobia. Am J Psychiatry 1986;143:1106-12. (Pubitemid 16041879)
-
(1986)
American Journal of Psychiatry
, vol.143
, Issue.9
, pp. 1106-1112
-
-
Mavissakalian, M.1
Michelson, L.2
-
25
-
-
0020696997
-
Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo
-
Zitrin CM, Klein DF, Woerner MG, Ross DC. Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 1983;40:125-38. (Pubitemid 13178009)
-
(1983)
Archives of General Psychiatry
, vol.40
, Issue.2
, pp. 125-138
-
-
Zitrin, C.M.1
Klein, D.F.2
Woerner, M.G.3
Ross, D.C.4
-
26
-
-
0034679102
-
Cognitive-behavioral therapy, imipramine, or their corn or their combination for panic disorder: A randomized controlled trial
-
Barlow DH, Gorman JM, Shear MK, Woods SW. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. JAMA 2000;283:2529-36. (Pubitemid 30324195)
-
(2000)
Journal of the American Medical Association
, vol.283
, Issue.19
, pp. 2529-2536
-
-
Barlow, D.H.1
Gorman, J.M.2
Shear, M.K.3
Woods, S.W.4
-
27
-
-
0028952254
-
Treatment of panic disorder with agoraphobia: Comparison of uvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone
-
De Beurs E, Van Balkom AJ, Lange A, Koele P, Van Dyck R. Treatment of panic disorder with agoraphobia: comparison of uvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. Am J Psychiatry 1995;152:683-91.
-
(1995)
Am J Psychiatry
, vol.152
, pp. 683-691
-
-
De Beurs, E.1
Van Balkom, A.J.2
Lange, A.3
Koele, P.4
Van Dyck, R.5
-
28
-
-
8944245858
-
Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia
-
DOI 10.1016/0887-6185(96)00008-4
-
Sharp DM, Power KG. Fluvoxamine, placebo and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia. J Anxiety Dis 1996;10:219-42. (Pubitemid 26245113)
-
(1996)
Journal of Anxiety Disorders
, vol.10
, Issue.4
, pp. 219-242
-
-
Sharp, D.M.1
Power, K.G.2
Simpson, R.J.3
Swanson, V.4
Moodie, E.5
Anstee, J.A.6
Pharm, B.7
Ashford, J.J.8
-
30
-
-
17144387322
-
Identifying outcome reporting bias in randomised trials on PubMed: Review of publications and survey of authors
-
Chan AW, Altman DG. Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors. BMJ 2005;330:753.
-
(2005)
BMJ
, vol.330
, pp. 753
-
-
Chan, A.W.1
Altman, D.G.2
-
31
-
-
2442692780
-
Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles
-
DOI 10.1001/jama.291.20.2457
-
Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291:2457-65. (Pubitemid 38669189)
-
(2004)
Journal of the American Medical Association
, vol.291
, Issue.20
, pp. 2457-2465
-
-
Chan, A.-W.1
Hrobjartsson, A.2
Haahr, M.T.3
Gotzsche, P.C.4
Altman, D.G.5
-
32
-
-
4844223081
-
Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
-
DOI 10.1503/cmaj.1041086
-
Chan AW, Krleza-Jeric K, Schmid I, Altman DG. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 2004;171:735-40. (Pubitemid 39319090)
-
(2004)
Canadian Medical Association Journal
, vol.171
, Issue.7
, pp. 735-740
-
-
Chan, A.-W.1
Krleza-Jeric, K.2
Schmid, I.3
Altman, D.G.4
-
33
-
-
70449633381
-
Outcome reporting in industry-sponsored trials of gabapentin for off-label use
-
Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med 2009;361:1963-71.
-
(2009)
N Engl J Med
, vol.361
, pp. 1963-1971
-
-
Vedula, S.S.1
Bero, L.2
Scherer, R.W.3
Dickersin, K.4
-
34
-
-
69349099139
-
Publication bias in clinical trials due to statistical significance or direction of trial results
-
MR000006
-
Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev 2009;1:MR000006.
-
(2009)
Cochrane Database Syst Rev
, vol.1
-
-
Hopewell, S.1
Loudon, K.2
Clarke, M.J.3
Oxman, A.D.4
Dickersin, K.5
-
35
-
-
33947684405
-
Epidemiology and reporting characteristics of systematic reviews
-
Moher D, Tetzlaff J, Tricco AC, Sampson M, Altman DG. Epidemiology and reporting characteristics of systematic reviews. PLoS Med 2007;4:e78.
-
(2007)
PLoS Med
, vol.4
-
-
Moher, D.1
Tetzlaff, J.2
Tricco, A.C.3
Sampson, M.4
Altman, D.G.5
-
36
-
-
68549101842
-
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration
-
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
-
(2009)
BMJ
, vol.339
-
-
Liberati, A.1
Altman, D.G.2
Tetzlaff, J.3
Mulrow, C.4
Gotzsche, P.C.5
Ioannidis, J.P.6
-
37
-
-
69449100622
-
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
-
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
-
(2009)
BMJ
, vol.339
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
38
-
-
77957342022
-
Effects of glucosamine, chondroitin or placebo for osteoarthritis of the hip or knee: Network meta-analysis
-
Wandel S, Juni P, Tendal B, Nuesch E, Villiger P, Welton N, et al. Effects of glucosamine, chondroitin or placebo for osteoarthritis of the hip or knee: network meta-analysis. BMJ 2010;341:c4675.
-
(2010)
BMJ
, vol.341
-
-
Wandel, S.1
Juni, P.2
Tendal, B.3
Nuesch, E.4
Villiger, P.5
Welton, N.6
-
39
-
-
52949141475
-
An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary
-
Harbord RM, Whiting P, Sterne JA, Egger M, Deeks JJ, Shang A, et al. An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary. J Clin Epidemiol 2008;61:1095-103.
-
(2008)
J Clin Epidemiol
, vol.61
, pp. 1095-1103
-
-
Harbord, R.M.1
Whiting, P.2
Sterne, J.A.3
Egger, M.4
Deeks, J.J.5
Shang, A.6
-
40
-
-
70349776188
-
PRISMAtic reporting of systematic reviews and meta-analyses
-
Juni P, Egger M. PRISMAtic reporting of systematic reviews and meta-analyses. Lancet 2009;374:1221-3.
-
(2009)
Lancet
, vol.374
, pp. 1221-1223
-
-
Juni, P.1
Egger, M.2
|